| Product Code: ETC7731483 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Japan's import shipments of antivirals continue to be sourced primarily from Germany, Switzerland, USA, Italy, and Metropolitan France. The market remains competitive with low concentration indicated by the Herfindahl-Hirschman Index (HHI). Despite a negative compound annual growth rate (CAGR) of -5.32% from 2020 to 2024, there was a slight improvement with a growth rate of -3.46% from 2023 to 2024. This suggests a stable but challenging market environment for antiviral imports in Japan, emphasizing the importance of strategic planning and market insights for industry players.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Antivirals Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Antivirals Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Antivirals Market - Industry Life Cycle |
3.4 Japan Antivirals Market - Porter's Five Forces |
3.5 Japan Antivirals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Antivirals Market Revenues & Volume Share, By Actions, 2021 & 2031F |
4 Japan Antivirals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of viral infections in Japan |
4.2.2 Growing awareness about the effectiveness of antivirals |
4.2.3 Technological advancements in antiviral drug development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of antiviral drugs in Japan |
4.3.2 High cost associated with antiviral drug development and treatment |
5 Japan Antivirals Market Trends |
6 Japan Antivirals Market, By Types |
6.1 Japan Antivirals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Antivirals Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Antivirals Market Revenues & Volume, By Hepatitis-C antivirals, 2021- 2031F |
6.1.4 Japan Antivirals Market Revenues & Volume, By HIV antivirals, 2021- 2031F |
6.1.5 Japan Antivirals Market Revenues & Volume, By Herpes antivirals, 2021- 2031F |
6.1.6 Japan Antivirals Market Revenues & Volume, By Hepatitis-B antivirals, 2021- 2031F |
6.1.7 Japan Antivirals Market Revenues & Volume, By Influenza antivirals, 2021- 2031F |
6.1.8 Japan Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Antivirals Market, By Actions |
6.2.1 Overview and Analysis |
6.2.2 Japan Antivirals Market Revenues & Volume, By DNA polymerase inhibitors, 2021- 2031F |
6.2.3 Japan Antivirals Market Revenues & Volume, By NS3 Protease inhibitors, 2021- 2031F |
6.2.4 Japan Antivirals Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.5 Japan Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Antivirals Market Import-Export Trade Statistics |
7.1 Japan Antivirals Market Export to Major Countries |
7.2 Japan Antivirals Market Imports from Major Countries |
8 Japan Antivirals Market Key Performance Indicators |
8.1 Research and development investment in antiviral drugs |
8.2 Number of new antiviral drug approvals in Japan |
8.3 Adoption rate of antiviral drugs in healthcare facilities |
9 Japan Antivirals Market - Opportunity Assessment |
9.1 Japan Antivirals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Antivirals Market Opportunity Assessment, By Actions, 2021 & 2031F |
10 Japan Antivirals Market - Competitive Landscape |
10.1 Japan Antivirals Market Revenue Share, By Companies, 2024 |
10.2 Japan Antivirals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here